Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliott Vichinsky

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
American Journal of Hematology|June 6, 2015
Fertility in transfusion-dependent thalassemia men: effects of iron burden on the reproductive axisSylvia T Singer, David Killilea, Jung H Suh, et al.
Pediatrics|July 3, 2003
Mycoplasma disease and acute chest syndrome in sickle cell diseaseLynne Neumayr, Evelyne Lennette, Dana Kelly, et al.
Transfusion|August 28, 2021
The transfusion management of beta thalassemia in the United StatesAshutosh Lal, Trisha Wong, Siobán Keel, et al.
British Journal of Haematology|November 14, 2021
An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centresJohn Chapin, Alan R Cohen, Ellis J Neufeld, et al.
Complementary Therapies in Medicine|July 17, 2022
The effects of glutamine supplementation on markers of apoptosis and autophagy in sickle cell disease peripheral blood mononuclear cellsPatrick B Walter, Leah S Hohman, Andrew Rokeby, et al.
Haematologica|June 17, 2008
Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemiaPaul Harmatz, Maureen M Jonas, Janet L Kwiatkowski, et al.
British Journal of Haematology|February 18, 2011
Red cell alloimmunization in a diverse population of transfused patients with thalassaemiaAlexis A Thompson, Melody J Cunningham, Sylvia T Singer, et al.
Haematologica|December 22, 2010
A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overloadHugh Young Rienhoff, Vip Viprakasit, Lay Tay, et al.
Pediatric Hematology and Oncology|March 6, 2010
Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapyEllen Butensky James, Hendrik J Vreman, Ronald J Wong, et al.
British Journal of Haematology|January 3, 2013
Pain in thalassaemia: the effects of age on pain frequency and severityDru Haines, Marie Martin, Susan Carson, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
American Journal of Hematology|June 6, 2015
Fertility in transfusion-dependent thalassemia men: effects of iron burden on the reproductive axisSylvia T Singer, David Killilea, Jung H Suh, et al.
Pediatrics|July 3, 2003
Mycoplasma disease and acute chest syndrome in sickle cell diseaseLynne Neumayr, Evelyne Lennette, Dana Kelly, et al.
Transfusion|August 28, 2021
The transfusion management of beta thalassemia in the United StatesAshutosh Lal, Trisha Wong, Siobán Keel, et al.
British Journal of Haematology|November 14, 2021
An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centresJohn Chapin, Alan R Cohen, Ellis J Neufeld, et al.
Complementary Therapies in Medicine|July 17, 2022
The effects of glutamine supplementation on markers of apoptosis and autophagy in sickle cell disease peripheral blood mononuclear cellsPatrick B Walter, Leah S Hohman, Andrew Rokeby, et al.
Haematologica|June 17, 2008
Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemiaPaul Harmatz, Maureen M Jonas, Janet L Kwiatkowski, et al.
British Journal of Haematology|February 18, 2011
Red cell alloimmunization in a diverse population of transfused patients with thalassaemiaAlexis A Thompson, Melody J Cunningham, Sylvia T Singer, et al.
Haematologica|December 22, 2010
A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overloadHugh Young Rienhoff, Vip Viprakasit, Lay Tay, et al.
Pediatric Hematology and Oncology|March 6, 2010
Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapyEllen Butensky James, Hendrik J Vreman, Ronald J Wong, et al.
British Journal of Haematology|January 3, 2013
Pain in thalassaemia: the effects of age on pain frequency and severityDru Haines, Marie Martin, Susan Carson, et al.
Pageof 14